| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.8M | -41.3% |
| Cost of Revenue | $8.4M | — |
| R&D Expense | $70.8M | -55.1% |
| SG&A Expense | $40.7M | -4.0% |
| Operating Income | -$115.1M | +40.0% |
| Income Tax | $0 | — |
| Net Income | -$113.0M | +41.2% |
| EPS (Basic) | -$4.24 | +50.0% |
| EPS (Diluted) | -$4.24 | +50.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $130.2M | -44.0% |
| Accounts Receivable | $308K | +68.3% |
| Current Assets | $133.3M | -43.6% |
| Total Assets | $169.3M | -36.3% |
| Current Liabilities | $12.7M | -33.7% |
| Total Liabilities | $42.6M | +33.6% |
| Stockholders' Equity | $126.7M | -45.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$100.1M | +41.6% |
| Capital Expenditures | $1.6M | -43.6% |
| Investing Cash Flow | -$1.6M | +43.6% |
| Financing Cash Flow | $406K | -99.8% |
| Free Cash Flow | -$101.8M | +41.6% |